CD274 and cancer: In contrast to SCLC tumors, which rarely respond strongly to T-cell checkpoint inhibitors, MC38 cells are a well-established model to investigate the responses of cytotoxic T cells against cancer cells, including PD-1/PD-L1 blockade39.